Pigmented Villonodular Synovitis: Clinical Trials

3 trials for Pigmented Villonodular Synovitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 2, Completed 1

Follow Pigmented Villonodular Synovitis: new trials by email Literature Review of Pigmented Villonodular Synovitis trials Research Report on Pigmented Villonodular Synovitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
Pimicotinib(ABSK021), Placebo - Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis
Phase 3Active not recruitingAbbisko Therapeutics Co, Ltd942023-04-272026-05-04
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
Vimseltinib, Placebo - Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis
Phase 3Active not recruitingDeciphera Pharmaceuticals, LLC1232021-10-142026-03-20
Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
Pexidartinib, Placebo - Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath
Phase 3CompletedDaiichi Sankyo1202015-05-112022-05-11

Narrower conditions

Giant Cell Tumor of Tendon Sheath (3)  ·  Synovitis, Pigmented Villonodular (3)

Broader conditions

Giant Cell Tumors (3)  ·  Joint Diseases (3)  ·  Muscular Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Synovitis (3)  ·  Tendinopathy (3)

Interventions

pexidartinib (1)

Sponsors

Abbisko Therapeutics Co, Ltd (1)  ·  Daiichi Sankyo (1)  ·  Deciphera Pharmaceuticals, LLC (1)

Countries

Canada (3)  ·  Italy (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Spain (3)  ·  United States (3)  ·  Australia (2)  ·  France (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  China (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Norway (1)

Results publications

PMID 27041409, PMID 31229240, PMID 32755241, PMID 33289960, PMID 36001000, PMID 37593881, PMID 38843860, PMID 39287124, PMID 41796601, PMID 42132251, PMID 42872549

NIH funding

2014 (1)